ArticleRNA (New York, N.Y.)2026

Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma.

Bozhi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.